# Maternal Probiotic Intervention to Improve Gut Health - Trial II - Burkina Faso (MPIGH-II)

> **NCT07134790** · PHASE2 · RECRUITING · sponsor: **University Ghent** · enrollment: 144 (estimated)

## Conditions studied

- Environmental Enteric Dysfunction (EED)

## Interventions

- **DRUG:** VE818
- **DRUG:** Placebo
- **DRUG:** Oral Vancomycin

## Key facts

- **NCT ID:** NCT07134790
- **Lead sponsor:** University Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-30
- **Primary completion:** 2026-07-07
- **Final completion:** 2027-06-07
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2025-11-17

## Collaborators

- Institut de Recherche en Sciences de la Santé (IRSS)
- Agence de Formation, de Recherche & d'Expertise en Santé pour l'Afrique (AFRICSanté)
- Bill and Melinda Gates Foundation

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07134790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07134790, "Maternal Probiotic Intervention to Improve Gut Health - Trial II - Burkina Faso (MPIGH-II)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07134790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*